General Information of Drug (ID: DMVNKNJ)

Drug Name
ION547 Drug Info
Indication
Disease Entry ICD 11 Status REF
Thrombosis DB61-GB90 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMVNKNJ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CSL312 DMV574J Hereditary angioedema 4A00.14 Phase 3 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Coagulation factor XII (F12) TTMXD0O FA12_HUMAN Not Available [1]

References

1 ClinicalTrials.gov (NCT04934891) A Double-Blind, Placebo-Controlled, Dose-Escalation Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ION547 Administered Subcutaneously to Healthy Subjects. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of CSL Behring.